Protara Therapeutics Growth Metrics (2014-2015) | TARA

Growth Metrics Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015
Growth Ratios
Assets Growth (1y) 198.95%
Assets (QoQ) 250.71%-4.56%-5.38%-5.60%
Capital Expenditures Growth (1y) 1,400.00%350.00%
Capital Expenditures (QoQ) -33.33%-16.67%520.00%335.48%-80.00%
Cash & Equivalents Growth (1y) 172.84%94.51%1,010.93%
Cash & Equivalents (QoQ) 141.10%-62.54%2,025.35%-85.79%71.88%113.97%
Cash from Investing Activities Growth (1y) -2,443.23%168.78%1,467.56%150.56%
Cash from Investing Activities (QoQ) -814.69%89.98%318.21%-1,599.95%120.98%99.16%-60.02%
Cash from Operations Growth (1y) -147.95%-72.04%-5.50%-152.98%
Cash from Operations (QoQ) -71.06%-38.70%44.68%-88.93%-18.69%14.94%-32.63%
EBITDA Margin (QoQ) 0.95M-0.99M-5.55M
EBIT Margin (QoQ) 0.84M-0.86M2.52M
EBIT (QoQ) -29.75%105.34%-2,542.54%
EBT Margin (QoQ) 0.84M-0.87M2.53M
EBT (QoQ) 8.11%106.07%-2,233.77%
Enterprise Value Growth (1y) 5,221.63%2,633.50%5.91%
Enterprise Value (QoQ) -141.10%1,829.70%-27.65%69.74%19.27%-27.69%
EPS (Basic) (QoQ) -2.54%-67.12%308.03%
FCF Margin (QoQ) 0.90M-0.93M1.59M
Free Cash Flow Growth (1y) -148.27%-73.20%-8.88%-153.55%
Free Cash Flow (QoQ) -71.06%-39.03%44.66%-88.62%-19.34%12.60%-28.88%
Interest Coverage Ratio (QoQ) -3,604.49%84.51%-1,778.87%
Net Cash Flow Growth (1y) -7,547.16%135.79%454.89%-93.76%
Net Cash Flow (QoQ) -2,559.39%72.28%1,313.26%-190.02%111.82%174.91%-78.66%
Net Income (QoQ) 8.11%106.07%-2,233.77%
Net Income towards Common Stockholders (QoQ) -2.69%-67.22%179.62%
Net Margin (QoQ) 1.49M-1.56M-4.54M
Operating Income (QoQ) -29.75%105.34%-2,542.54%
Operating Margin (QoQ) 0.84M-0.86M2.52M
Profit After Tax (QoQ) 9.47%-102.15%239.61%
Property, Plant & Equipment (Net) Growth (1y) 156.98%
Property, Plant & Equipment (Net) (QoQ) -3.49%-3.61%27.50%116.67%
Revenue (QoQ) 96.50%10,100.00%-100.45%
Share-based Compensation Growth (1y) 2,294.12%1,387.50%230.27%197.78%
Share-based Compensation (QoQ) 88.24%478.13%21.62%80.89%16.95%28.36%9.66%
Shareholder's Equity Growth (1y) 159.23%
Shareholder's Equity (QoQ) 170.75%-5.05%-5.79%-6.41%